Colorectal Cancer
Colorectal cancer prognosticated by sentinel lymph node mapping
Published in Cancer Weekly, May 15th, 2006
"SLNM for staging in CRCa remains controversial and needs to be validated. This study analyzes results of SLNM at a multi-institutional level for CRCa. Group A patients underwent SLNM with 1 to 3 mL of 1% lymphazurin," researchers in the United States reported.
"First 1 to 4 blue lymph nodes were designated as SLNs and had focused analysis. Group B had standard resection and nodal staging. Patients with a minimum of 2 years of follow-up were analyzed for recurrence. Overall nodal metastasis were 50% for 500 group A patients versus 35% for 368 group B patients....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-05-15)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer evaluation by FDG-PET/CT preferred over PET or CT alone - Glioma
Glioma sensitized to cancer therapy by HA14-1 - Hepatic Cancer
Hepatic cancer diagnosed more accurately with intraoperative ultrasonography - Lung Cancer
Lung cancer risk linked to polymorphisms of ataxia telangiectasia mutated gene - Prostate Cancer
Low-risk prostate cancer patients do not need immediate treatment - Acute Myeloid Leukemia
Myeloid HSCs with minimal lymphopoietic potential may be AML transformation site - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
